Interest in Genetic Testing Brings Precision Medicine Challenges

HealthIT Analytics – Close to two-thirds of consumers would like to take part in genetic testing to better understand their health risks, according to a new survey from Wamberg Genomic Advisors, which could be both a boon and a bother for big data analytics and precision medicine programs.

While a massive influx of genetic data could help precision medicine analysts identify population patterns, create new risk analytics, and develop innovative therapies for rare conditions, front-line providers may still feel unprepared to address genetic issues and answer a slew of time-consuming questions from individuals who may feel overly anxious about their test results.

Read more at HealthIT Analytics.

News Image
DNA sequence alignment data shown on the TACC Visualization Wall
Image Citation

Andrew LenardsCC BY-NC-SA 2.0